Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Bull Exp Biol Med ; 150(6): 693-5, 2011 Apr.
Article in English | MEDLINE | ID: mdl-22235419

ABSTRACT

Experiments on Wistar rats showed that single intraperitoneal injection nonselective NO-synthase inhibitor L-NAME in a dose of 50 mg/kg was followed by transient proteinuria and albuminuria. This effect was not reproduced by injection of ODQ, an inhibitor of intracellular effects of NO, and arginine, but D-NAME, an optical isomer of L-NAME not blocking NO-synthase, produced similar, though less pronounced effect. The degree of proteinuria and albuminuria increased in combined treatment with nitroarginine methyl esters and 1-deamino-arginine vasotocin or arginine vasopressin. Proteinuria during treatment with arginine derivatives attests to not only their effect on the charge of the filtration membrane, but also the participation of NO-dependent processes in the regulation of ultrafiltration in renal glomeruli.


Subject(s)
Albumins/biosynthesis , Kidney/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide/biosynthesis , Albumins/metabolism , Albuminuria/metabolism , Animals , Arginine Vasopressin/administration & dosage , Arginine Vasopressin/pharmacology , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Female , Kidney Glomerulus/metabolism , NG-Nitroarginine Methyl Ester/administration & dosage , NG-Nitroarginine Methyl Ester/analogs & derivatives , NG-Nitroarginine Methyl Ester/pharmacology , Nitroarginine/administration & dosage , Nitroarginine/analogs & derivatives , Nitroarginine/pharmacology , Proteinuria/metabolism , Rats , Rats, Wistar , Vasotocin/administration & dosage , Vasotocin/analogs & derivatives , Vasotocin/pharmacology
2.
Behav Neurosci ; 119(6): 1656-61, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16420168

ABSTRACT

Turtles (Chrysemys picta) were given the nitric oxide synthase inhibitor NW-nitro-L-arginine methyl ester (L-NAME) or its inactive isomer NW-nitro-D-arginine methyl ester (D-NAME) and were trained on a negative patterning task or a simple go/no-go discrimination task. L-NAME impaired the learning of negative patterning but did not affect retention of the task if it had already been learned. D-NAME had no effect. Go/no-go discrimination learning was not affected by L-NAME. These findings support the notion that nitric oxide plays a role in complex configural learning in a reptile closely related to the ancestors of mammals.


Subject(s)
Learning/physiology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/antagonists & inhibitors , Turtles/physiology , Animals , Behavior, Animal , Choice Behavior/drug effects , Choice Behavior/physiology , Discrimination Learning/drug effects , Discrimination Learning/physiology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Learning/drug effects , NG-Nitroarginine Methyl Ester/analogs & derivatives , Probability , Time Factors
3.
Acta Physiol Scand ; 175(3): 201-9, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12100359

ABSTRACT

UNLABELLED: We investigated the vascular endothelial growth factor (VEGF) receptor [fms-like-tyrosine kinase (Flt-1 and fetal liver kinase-1 (Flk-1)] response to acute exercise. In female Wistar rats, the VEGF receptor messenger RNA (mRNA) response to a single acute exercise bout was examined using semi-quantitative Northern blot from the left gastrocnemius muscles at rest and post-exercise at 0, 1, 2, 4, 8, 16, 24 and 48 h. Exercise altered both Flt-1 and Flk-1 mRNA, with significant increases in Flt-1 mRNA at 1 and 24 h. However, post-hoc analysis was unable to discern the time point where a significant increase in Flk-1 mRNA occurred. To investigate the regulation of Flt-1 mRNA by exercise we examined if nitric oxide synthase (NOS) inhibition alters the Flt-1 mRNA response. Eight groups [ CONDITION: Rest or Exercise; Drug: Saline, 30 mg kg(-1)N(omega)-nitro-L-arginine methyl ester (L-NAME), 300 mg kg(-1) L-NAME or 300 mg kg(-1) D-NAME] were used to determine the effect of NOS inhibition on the Flt-1 mRNA response to exercise. L-NAME, a known NOS inhibitor, attenuated the exercise-induced increase in Flt-1 mRNA by approximately 50%. These findings suggest that: (1) exercise alters Flt-1 and Flk-1 gene expression; and (2) NO is important in the regulation of the Flt-1 gene response to exercise.


Subject(s)
Extracellular Matrix Proteins/genetics , Muscle, Skeletal/physiology , Nitric Oxide Synthase/antagonists & inhibitors , Physical Exertion/physiology , Animals , Endothelial Growth Factors , Enzyme Inhibitors/pharmacology , Extracellular Matrix Proteins/drug effects , Female , Gene Expression/drug effects , Gene Expression/physiology , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Intercellular Signaling Peptides and Proteins , Lymphokines , NG-Nitroarginine Methyl Ester/analogs & derivatives , NG-Nitroarginine Methyl Ester/pharmacology , RNA, Messenger/metabolism , RNA, Ribosomal, 18S/genetics , Rats , Rats, Wistar , Reproducibility of Results , Sensitivity and Specificity , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factor Receptor-1/genetics , Vascular Endothelial Growth Factor Receptor-2/genetics , Vascular Endothelial Growth Factors
4.
Biochem Biophys Res Commun ; 257(1): 145-8, 1999 Apr 02.
Article in English | MEDLINE | ID: mdl-10092524

ABSTRACT

This study is the first to demonstrate activation of NF-kappaB binding just 10 minutes into the commonly employed hepatocyte isolation procedure. It is further reported that the anti-oxidant Trolox can prevent the induction of NF-kappaB during the well established hepatocyte isolation procedure but not during their subsequent culture. However both phases of NF-kappaB activation are inhibited by L-NAME intimating a role for NO production, via nitric oxide synthase. These findings demonstrate that at least 2 different signal transduction pathways are operative during hepatocyte isolation and culture. Thus further studies employing Trolox and L-NAME will help delineate how each pathway contributes to the generalised loss of liver function commonly observed in vitro.


Subject(s)
Cell Separation , Liver/cytology , NF-kappa B/metabolism , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/metabolism , Acetylcysteine/pharmacology , Animals , Antioxidants/pharmacology , Binding, Competitive , Cell Culture Techniques , Cell Survival/drug effects , Cells, Cultured , Chromans/pharmacology , Dithiothreitol/pharmacology , Enzyme Inhibitors/pharmacology , Liver/drug effects , Liver/enzymology , Liver/metabolism , Male , NF-kappa B/antagonists & inhibitors , NG-Nitroarginine Methyl Ester/analogs & derivatives , Nitrates/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Oligonucleotides/genetics , Oligonucleotides/metabolism , Protein Binding/drug effects , Rats , Rats, Sprague-Dawley , Response Elements/genetics , Time Factors
5.
Acta Physiol Scand ; 161(4): 527-32, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9429661

ABSTRACT

Duodenal mucosal alkaline secretion increases in response to hydrochloric acid exposure. The tentative role of nitric oxide (NO) in the mediation of this response was investigated. The mucosal alkaline output by a duodenal segment was recorded by in situ titration in chloralose-anaesthetized rats. In some experiments the duodenal blood flow was estimated by laser-Doppler flowmetry. Exposure of the duodenum to acid (0.01 M HCl, 5 min) increased the alkaline secretion by approximately 85%. The NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME, 10 mg kg-1 intravenously or 0.3 mM intraluminally) blocked the secretory increment after mucosal acid exposure. Mean arterial pressure and basal alkaline secretion were markedly raised, whereas duodenal blood flow was decreased, when L-NAME was given intravenously (i.v.). Intraluminal (i.l.) administration left mean arterial pressure as well as duodenal blood flow unaltered, and the duodenal mucosal alkaline secretion was only slightly elevated. The stereoisomer NG-nitro-D-arginine methyl ester (D-NAME) had no effect on either basal or acid-induced duodenal alkaline output. In animals receiving L-arginine (10 mg kg-1 min-1 i.v., or 3 mM i.l.) and L-NAME, the acid exposure elicited an increase in duodenal mucosal alkaline secretion, similar to that observed in controls. The results suggest that the acid-induced increase in duodenal mucosal alkaline secretion involves NO synthesis, which takes place close to the lumen, probably within the mucosa.


Subject(s)
Arginine/physiology , Duodenum/drug effects , Duodenum/metabolism , Hydrochloric Acid/pharmacology , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Nitric Oxide/physiology , Animals , Arteries , Blood Flow Velocity/drug effects , Blood Flow Velocity/physiology , Blood Pressure/drug effects , Blood Pressure/physiology , Duodenum/blood supply , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Infusions, Intravenous , Male , NG-Nitroarginine Methyl Ester/administration & dosage , NG-Nitroarginine Methyl Ester/analogs & derivatives , NG-Nitroarginine Methyl Ester/pharmacology , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...